Sharda Cropchem Limited has informed the Exchange regarding Board meeting held on May 14, 2025 considered and approved the Audited Consolidated Financial Results and Audited Standalone Financial Results of the Company for the financial year ended 31st March, 2025
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.6 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sharda Cropchem's Board approved audited consolidated and standalone financial results for FY25 on May 14, 2025, with auditor BSR & Co. LLP giving an unqualified (clean) opinion. Consolidated revenue from operations grew strongly by about 37% to Rs 4,31,985 lakhs from Rs 3,16,302 lakhs in FY24. Profit after tax surged dramatically to Rs 30,442 lakhs from Rs 3,191 lakhs in FY24, while profit before tax rose over five-fold to Rs 37,834 lakhs. Earnings per share jumped to Rs 33.74 from Rs 3.53. Operating cash flow was healthy at Rs 60,362 lakhs, and the company paid off all borrowings. The Board also recommended a final dividend of Rs 6 per share (face value Rs 10) for FY25, subject to shareholder approval.
Exceptional year for Sharda Cropchem with sharp improvement in both revenue and profitability, reflecting strong business momentum in the agrochemicals segment. The clean audit, debt-free balance sheet, robust operating cash flow, and final dividend declaration are positive for shareholders and likely supportive of the stock price.